Alzheimer's Treatment Centers of America
Neurologist – Healthcare Executive Advisory Board Member
Alzheimer's Treatment Centers of America, New York, New York, United States
About Alzheimer’s Treatment Centers of America (ATCA)
Alzheimer’s Treatment Centers of America uses Artificial Intelligence (AI) + Personalized Precision Medicine to transform the treatment of Alzheimer’s disease, dementia, and brain fog from Long COVID.
This is not about research. This is about treating patients. ATCA goes beyond diagnosing Alzheimer’s and dementia to uncover and address root causes through our innovative treatment protocols.
Our multidisciplinary team, which includes top business executives and medical professionals with expertise in virtual reality and artificial intelligence, is leading the rollout of ATCA Clinics across the U.S.
Why Now?
Immediate Revenue: ATCA is expanding to a multi-clinic organisation incorporating a new prime location...We're Launching Our New Clinic in Palm Beach Gardens, Florida. The Alzheimer's Treatment Centers of America ATCA clinic Palm Beach Gardens/Jupiter is located on the first floor of a two storey building with the Cleveland Clinic as a neighboring tenant. It is located in one of the most affluent areas and has replaced a prior urgent care space which has resulted in high levels of uptake with appointments already booked as far as March.
In-Network with Insurance: ATCA treatments are covered by Medicare, Medicare Advantage, and most major healthcare insurance providers.
Proven Results: In a study using the AI protocol implemented by ATCA, 75% of patients with mild cognitive impairment experienced no further decline.
FDA-Approved Treatment: Includes TB006, which is FDA-approved for compassionate use and has the potential to reverse dementias, including Alzheimer’s.
Physician-Supported: ATCA’s protocols are backed by an experienced Medical Advisory Board of top doctors and scientists. See our Medical Advisory Board:
https://atca.ai/medical-advisory-board/ Key Achievements Proven AI Protocol: Combines cutting-edge AI and precision medicine to deliver highly personalized treatment solutions. Scalable Model: Clinics are designed to deliver a 44% EBITDA margin, supported by strong unit economics. Market Opportunity: The U.S. Alzheimer’s treatment market is valued at $355 billion, with a global opportunity of $1.5 trillion. Research-Driven Care: Clinics also serve as micro-research facilities to advance innovation and generate future revenue streams. Neurologist Job Description ATCA is seeking an accomplished Neurologist to join its Medical Advisory Board and support the clinical and strategic expansion of a next-generation treatment model for Alzheimer’s disease and cognitive decline. This role is designed for senior neurologists who want to apply their expertise beyond traditional care settings and contribute to shaping how AI-driven precision medicine is delivered at scale. As a Neurologist Advisor, you will help guide clinical protocols, interpret complex neurological data, and ensure that ATCA’s treatment model aligns with best-in-class neurological standards while remaining scalable across a growing national clinic network. You will work closely with ATCA’s executive leadership, clinical teams, and data science partners to refine treatment pathways, improve patient outcomes, and support the responsible integration of AI into neurological care. Responsibilities Include Clinical Strategy & Oversight: Provide expert guidance on neurological evaluation, diagnosis, and treatment protocols for Alzheimer’s disease, dementia, and related cognitive disorders. Protocol Development: Contribute to the refinement of AI-assisted diagnostic tools, cognitive assessments, and personalized treatment pathways based on neurological best practices. Precision Medicine Integration: Advise on how neurological data, imaging, biomarkers, and patient history should inform individualized treatment decisions within ATCA’s AI-driven platform. Quality & Outcomes Review: Review aggregated, de-identified patient outcomes to ensure clinical quality, safety, and continuous improvement across clinics. Interdisciplinary Collaboration: Collaborate with physicians, pharmacists, technologists, and executive leadership to align neurological care with operational scalability and patient experience. Innovation Support: Provide input on emerging neurological research, technologies, and therapies that may enhance ATCA’s clinical offerings and long-term roadmap.
Why Join Us? Transform Patient Outcomes: Help advance a new model of Alzheimer’s treatment that prioritizes root-cause resolution and measurable cognitive improvement. Influence National Care Delivery: Play a meaningful role in shaping how neurological care is delivered across a growing network of clinics nationwide. Collaborate with Leaders: Work alongside a world-class team of physicians, scientists, AI experts, and healthcare executives. Be Part of a Defining Moment: Join ATCA at a critical stage of expansion where clinical leadership directly impacts growth, outcomes, and legacy. Compensation / Perks Equity Options: Receive stock options in recognition of your clinical leadership and advisory contributions to ATCA’s mission. Investment Access: Select advisory board members may be offered access to ATCA’s current financing round. Participation is optional and independent of the advisory role. Equal Opportunity Commitment ATCA is committed to fostering an inclusive environment. We believe diversity drives innovation and welcome individuals from all backgrounds to join us in transforming Alzheimer’s treatment.
https://atca.ai/medical-advisory-board/ Key Achievements Proven AI Protocol: Combines cutting-edge AI and precision medicine to deliver highly personalized treatment solutions. Scalable Model: Clinics are designed to deliver a 44% EBITDA margin, supported by strong unit economics. Market Opportunity: The U.S. Alzheimer’s treatment market is valued at $355 billion, with a global opportunity of $1.5 trillion. Research-Driven Care: Clinics also serve as micro-research facilities to advance innovation and generate future revenue streams. Neurologist Job Description ATCA is seeking an accomplished Neurologist to join its Medical Advisory Board and support the clinical and strategic expansion of a next-generation treatment model for Alzheimer’s disease and cognitive decline. This role is designed for senior neurologists who want to apply their expertise beyond traditional care settings and contribute to shaping how AI-driven precision medicine is delivered at scale. As a Neurologist Advisor, you will help guide clinical protocols, interpret complex neurological data, and ensure that ATCA’s treatment model aligns with best-in-class neurological standards while remaining scalable across a growing national clinic network. You will work closely with ATCA’s executive leadership, clinical teams, and data science partners to refine treatment pathways, improve patient outcomes, and support the responsible integration of AI into neurological care. Responsibilities Include Clinical Strategy & Oversight: Provide expert guidance on neurological evaluation, diagnosis, and treatment protocols for Alzheimer’s disease, dementia, and related cognitive disorders. Protocol Development: Contribute to the refinement of AI-assisted diagnostic tools, cognitive assessments, and personalized treatment pathways based on neurological best practices. Precision Medicine Integration: Advise on how neurological data, imaging, biomarkers, and patient history should inform individualized treatment decisions within ATCA’s AI-driven platform. Quality & Outcomes Review: Review aggregated, de-identified patient outcomes to ensure clinical quality, safety, and continuous improvement across clinics. Interdisciplinary Collaboration: Collaborate with physicians, pharmacists, technologists, and executive leadership to align neurological care with operational scalability and patient experience. Innovation Support: Provide input on emerging neurological research, technologies, and therapies that may enhance ATCA’s clinical offerings and long-term roadmap.
Why Join Us? Transform Patient Outcomes: Help advance a new model of Alzheimer’s treatment that prioritizes root-cause resolution and measurable cognitive improvement. Influence National Care Delivery: Play a meaningful role in shaping how neurological care is delivered across a growing network of clinics nationwide. Collaborate with Leaders: Work alongside a world-class team of physicians, scientists, AI experts, and healthcare executives. Be Part of a Defining Moment: Join ATCA at a critical stage of expansion where clinical leadership directly impacts growth, outcomes, and legacy. Compensation / Perks Equity Options: Receive stock options in recognition of your clinical leadership and advisory contributions to ATCA’s mission. Investment Access: Select advisory board members may be offered access to ATCA’s current financing round. Participation is optional and independent of the advisory role. Equal Opportunity Commitment ATCA is committed to fostering an inclusive environment. We believe diversity drives innovation and welcome individuals from all backgrounds to join us in transforming Alzheimer’s treatment.